Evidence map›Paper›PMID 30804996›Full record

ArticleGastroenterology research and practice2019

The Value of Pepsinogen in GC Screening: A Systematic Review and Meta-Analysis.

Ling Liu, Junjie Lang, Yuelong Jin, Yan Chen, Weiwei Chang, Yingshui Yao, Jiegen Yu

Abstract read
In one paragraph

Article in Gastroenterology research and practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Article
  2. World journal of gastrointestinal oncology · 2025
    Review
  3. The Aging Stomach: Clinical Implications ofInternational journal of molecular sciences · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Focusing onFrontiers in cellular and infection microbiology · 2023
    Review
  8. Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ling LiuSchool of Public Health, Wannan Medical College, 241002, China.
Junjie LangSchool of Public Health, Wannan Medical College, 241002, China.
Yuelong JinSchool of Public Health, Wannan Medical College, 241002, China.
Yan ChenSchool of Public Health, Wannan Medical College, 241002, China.
Weiwei ChangSchool of Public Health, Wannan Medical College, 241002, China.
Yingshui YaoSchool of Public Health, Wannan Medical College, 241002, China.ORCID 0000-0002-6690-4585
Jiegen YuSchool of Humanities and Management Science, Wannan Medical College, Wenchang West Road, 22 Wuhu, China.ORCID 0000-0001-5658-4920

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe current gold standard for gastric cancer (GC) screening is pathology or a barium meal followed by X-ray. This is not applicable to a wide range of screening capabilities due to the lack of operability. This article used a meta-analysis to evaluate the value of pepsinogen (PG) screening for GC.

methodsPubMed, EMbase, the Cochrane Library, CNKI, WanFang, VIP, and CBM databases were systematically searched for published studies that used serum PG to diagnose GC. Articles were searched from January 2003 to January 2018. Two reviewers independently screened the literature according to specified inclusion and exclusion criteria. The data were extracted and evaluated, and the quality of the methodologies evaluated using the QUADAS entry. The meta-analysis (MA) was performed using Meta-DiSc 1.4 software. Stata 12.0 software was used to assess publication bias.

resultsA total of 19 studies were finally included from a total of 169,009 cases. The MA showed a combined sensitivity and specificity of 0.56 (95% CI (0.53-0.59),

conclusionsSerum PG provides medium levels of sensitivity and specificity for GC assessment. To be used in a clinical setting, further high-quality research must be performed and verified.

Identifiers

PMID30804996
PMCPMC6360615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.